跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
biological therapeutic (autoimmune diseases)
首页
药物
biological therapeutic (autoimmune diseases)
biological therapeutic (autoimmune diseases)
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Compositions and methods for modulating the immune system
US 7723290 B2
申请人: BIOINCEPT LLC
优先权: 2006
US
10 件公开
Anti-CD79 antibodies and their uses
US 11078276 B2
申请人: NEPENTHE BIOSCIENCE LLC
优先权: 2018
CN
US
WO
6 件公开
IL-18 BINDING MOLECULES
EP 3725805 A1
申请人: NOVARTIS AG
优先权: 2012
EP
US
6 件公开
Lipid raft, caveolin protein, and caveolar function modulation compounds and associated synthetic and therapeutic methods
US 8026382 B2
申请人: KAY HEIDI
优先权: 2008
US
5 件公开
Glycan-based drugs, therapies and biomarkers
US 9119866 B2
申请人: WANG HUIRU
优先权: 2010
US
4 件公开
PIF peptides biologic activities, site of action, and the antibody to detect PIF
US 2009081225 A1
申请人: BARNEA EYTAN R
优先权: 2004
US
3 件公开
SELECTIVE PEPTIDES THAT INHIBIT THE BIOLOGICAL ACTIVITY OF CALCINEURIN
US 2010081624 A1
申请人: CONSEJO SUPERIOR INVESTIGACION
优先权: 2005
US
3 件公开
Method for inhibiting or reducing transplant rejection by adminstration of interleukin-34
US 10155025 B2
申请人: INST NAT SANTE RECH MED
优先权: 2014
US
3 件公开
Hydroxyphenyl pyrrole compounds containing an hydroxamic acid as hdac inhibitors and medicinal applications thereof
EP 2508510 A1
申请人: IKERCHEM S L
优先权: 2011
EP
US
2 件公开
AUTOIMMUNE DISEASE THERAPEUTIC AGENT INCLUDING OLIGONUCLEOTIDE THAT SELECTIVELY BINDS TO IFN-y, AND SAID OLIGONUCLEOTIDE
US 20250325674 A1
申请人: TAGCYX BIOTECHNOLOGIES INC
优先权: 2021
CN
US
2 件公开
第 1 / 4 页
上一页
下一页
药物
反馈